C. R. Bard (Murray Hill, New Jersey) completed its previously reported acquisition of Venetec International (San Diego, California). The deal for the purchase of Venetec for $166 million was first reported in March. Venetec’s StatLock line of catheter securement products now will be marketed by Bard’s Medical division in Covington, Georgia. C. R. Bard provides vascular, urology, oncology and surgical specialties technologies.

Merit Medical Systems (South Jordan, Utah) reported completing an asset acquisition, with cash, of a hemostasis valve from Millimed (Roskilde, Denmark). The agreement calls for transfer and startup requirements, with a maximum payment of $1.5 million. Hemostasis valves are used during interventional procedures to allow passage into the vasculature of various devices, including stents and PTCA balloons, while minimizing blood loss. Merit said that the product extends its leadership in this space and is complementary to its inflation device business. It said that regulatory approvals are in place with market release estimated to be in early May. The product will be manufactured in Merit’s Galway, Ireland, facility. Founded in 1987, Merit manufactures and distributes disposable medical accessories used in interventional and diagnostic procedures, particularly in cardiology and radiology.

Zoll Medical (Chelmsford, Massachusetts), a manufacturer of resuscitation devices and related software solutions, reported completing the purchase of the assets of Lifecor (Pittsburgh), a manufacturer of wearable external defibrillator systems. Zoll acquired Lifecor’s assets and business, assumed Lifecor’s outstanding debt of about $5.8 million (plus an additional $3 million owed to Zoll), and also assumed certain stated liabilities of around $1.5 million. Additional consideration will be in the form of earn-out payments to Lifecor based upon future revenue growth of the acquired business over a five-year period. Zoll on March 22 reported exercise of a previously granted option to acquire the assets. Zoll will operate the Lifecor business through its Lifecor subsidiary, which will be based out of Pittsburgh.